Suppr超能文献

前列腺素和巯基可能介导维拉帕米对大鼠的胃保护作用。

Prostaglandins and sulfhydryls may mediate gastric protection induced by verapamil in rats.

作者信息

Gutiérrez-Cabano C A

机构信息

Department of Surgical Pathology II, Faculty of Medical Sciences, National University of Rosario, Argentina.

出版信息

Dig Dis Sci. 1993 Nov;38(11):2043-8. doi: 10.1007/BF01297083.

Abstract

Verapamil, a type-1 calcium-channel blocker, given intraperitoneally, macroscopically protected the gastric mucosa of rats from 96% ethanol-induced lesions in a dose-dependent fashion. This effect was significant when verapamil at 10 or 20 mg/kg was given 1 hr before ethanol. Histopathologically, verapamil prevented the development of deep necrotic lesions, but did not preserve the surface epithelium. Gastric acid secretion in both pylorus-ligated rats and gastric-diversion rats was inhibited by 20 mg/kg of verapamil. Gastric motility measured by a balloon method was dose-dependently inhibited by verapamil. Verapamil protection was significantly diminished by pretreatment with subcutaneous indomethacin (30 mg/kg) and iodoacetamide (100 mg/kg). The gastric motility inhibited by verapamil was not reversed by indomethacin and iodoacetamide. These results indicate the participation of both endogenous prostaglandins and sulfhydryls of the gastric mucosa in verapamil protection against ethanol damage, but do not relate to a suppression of gastric motility.

摘要

维拉帕米,一种1型钙通道阻滞剂,腹腔注射时,能以剂量依赖的方式宏观上保护大鼠胃黏膜免受96%乙醇诱导的损伤。当在乙醇给药前1小时给予10或20mg/kg的维拉帕米时,这种作用显著。组织病理学上,维拉帕米可防止深层坏死性病变的发展,但不能保留表面上皮。20mg/kg的维拉帕米可抑制幽门结扎大鼠和胃分流大鼠的胃酸分泌。用气囊法测量的胃动力受到维拉帕米的剂量依赖性抑制。皮下注射吲哚美辛(30mg/kg)和碘乙酰胺(100mg/kg)预处理可显著减弱维拉帕米的保护作用。吲哚美辛和碘乙酰胺不能逆转维拉帕米抑制的胃动力。这些结果表明内源性前列腺素和胃黏膜巯基均参与了维拉帕米对乙醇损伤的保护作用,但与胃动力的抑制无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验